onlinelibrary.wiley.com/doi/10.1111/...
Thrilled to share our work in BJH highlighting the therapeutic potential of targeting the WNT pathway to block the crosstalk among stromal and leukemic ALL cells to prevent chemoresistance.
Collab. w/ Bela Wrench
@foteinikal.bsky.social
@qmbci.bsky.social
Congratulations to Professor Michelle Lockley and Dr Oliver Pearce, who have been awarded prestigious @cancerresearchuk.org Programme Foundation Awards, worth nearly £1.5m each. Read more about their work seeking novel cancer therapy targets in our Q&A.
🧪 #medsky #oncosky @qmul.bsky.social
Today, on #WorldCancerDay, we’re taking you behind the scenes at Queen Mary's Barts Cancer Institute and introducing you to the people who are making progress possible.
Follow us to stay up to date with new developments.
🧪 #UnitedByUnique #MedSky #OncoSky @qmul.bsky.social @cancerresearchuk.org
www.bci.qmul.ac.uk
YouTube video by BCIQMUL
youtu.be
Professor Michelle Lockley and Dr Oliver Pearce have both been awarded prestigious Programme Foundation Awards from Cancer Research UK, worth nearly £1.5 million each, to support the work of their res...
Chemotherapy-induced WNT ligand secretion by bone marrow (BM) stroma drives acute lymphoblastic leukaemia (ALL) chemoresistance. WNT pathway inhibition disrupts this cross-talk and restores therapeut....
onlinelibrary.wiley.com
Margaret, a participant in the study, has lived with her cancer for more than 13 years since her original diagnosis in 2012.
💬“I’m eternally grateful that Professor Kocher has given me all of these extra years to enjoy with my loved ones,” Margaret comments.
Ganuza Lab
Barts Cancer Institute (Queen Mary University of London)
Barts Cancer Institute (Queen Mary University of London)
